Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has provided an update.
Fuso Pharmaceutical Industries, Ltd. announced board-level personnel changes following a May 12, 2026 directors’ meeting, marking a planned transition in its production leadership. Director and Production Division General Manager Jun-ichi Oka will retire on June 24, 2026, and current Deputy General Manager Kazuaki Yuasa will be promoted to Senior Executive Officer and General Manager of the Production Division on the same date.
The reshuffle concentrates operational authority in Yuasa’s expanded remit over the Production Division, signaling continuity in manufacturing management while refreshing the top leadership overseeing output and quality. These changes may help maintain stability in Fuso’s production operations and governance as it navigates future market and regulatory demands in the pharmaceutical sector.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. is a Japan-based drug manufacturer listed on the Tokyo Stock Exchange Prime Market under securities code 4538. The company operates in the pharmaceutical industry, focusing on the production and supply of medicines and related products for the healthcare sector.
Average Trading Volume: 31,458
Technical Sentiment Signal: Hold
Current Market Cap: Yen19.28B
For detailed information about 4538 stock, go to TipRanks’ Stock Analysis page.